Michael C Keefer

Michael C Keefer

UNVERIFIED PROFILE

Are you Michael C Keefer?   Register this Author

Register author
Michael C Keefer

Michael C Keefer

Publications by authors named "Michael C Keefer"

Are you Michael C Keefer?   Register this Author

51Publications

1283Reads

50Profile Views

IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine.

Vaccine 2019 Apr 27;37(17):2322-2330. Epub 2019 Mar 27.

Infectious Diseases Division, University of Rochester Medical Center, Rochester, NY, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2019.03.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506229PMC
April 2019

Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial.

AIDS Res Hum Retroviruses 2016 Oct/Nov;32(10-11):1143-1148

1 Infectious Diseases Division, Department of Medicine, University of Rochester , Rochester, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/AID.2016.0150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067846PMC
December 2017

Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials.

Vaccine 2015 May 25;33(20):2347-53. Epub 2015 Mar 25.

Infectious Diseases Division, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 689, Rochester, NY 14642-0002, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2015.03.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433533PMC
May 2015

9G4+ antibodies isolated from HIV-infected patients neutralize HIV-1 and have distinct autoreactivity profiles.

PLoS One 2013 26;8(12):e85098. Epub 2013 Dec 26.

Lowance Center for Human Immunology and Division of Rheumatology, Department of Medicine, Emory University, Atlanta, Georgia, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085098PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873436PMC
February 2015

Theoretical model of critical issues in informed consent in HIV vaccine trials.

AIDS Care 2014 28;26(11):1452-60. Epub 2014 May 28.

a Department of Public Health Sciences , University of Rochester Medical Center , Rochester , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09540121.2014.920074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122591PMC
January 2015

Bridging the digital divide in HIV care: a pilot study of an iPod personal health record.

J Int Assoc Provid AIDS Care 2013 Mar-Apr;12(2):117-21. Epub 2012 Sep 10.

Department of Medicine, Infectious Disease Division, University of Rochester School of Medicine & Dentistry, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1545109712457712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679286PMC
August 2013

Barriers and Facilitators of Online Patient Portals to Personal Health Records Among Persons Living With HIV: Formative Research.

JMIR Res Protoc 2013 Jan 22;2(1):e8. Epub 2013 Jan 22.

Department of Medicine, Infectious Disease Division, University of Rochester School of Medicine & Dentistry, Rochester, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2196/resprot.2302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628162PMC
January 2013

HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime.

Vaccine 2007 Oct 30;25(42):7410-21. Epub 2007 Aug 30.

Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2007.08.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2092414PMC
October 2007

Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.

Vaccine 2007 Feb 15;25(9):1634-46. Epub 2006 Nov 15.

Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2006.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851942PMC
February 2007

Safety profile of recombinant canarypox HIV vaccines.

Vaccine 2004 Jan;22(5-6):704-13

HIV Vaccines Trials Network Core Operations, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2003.08.023DOI Listing
January 2004